Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.68 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.61 |
| ▸ | DGKA | P23743 | 2/20 | 0.57 |
| ▸ | MGLL | Q99685 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | CNR1 | P21554 | 1/20 | 0.52 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.49 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.49 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.49 |
| ▸ | PRKCA | P17252 | 1/20 | 0.49 |
| ▸ | FAAH | O00519 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28588138 | 0.99 | DNM1 (0.67) | DNM1EPHX2DGKAMGLLALDH1A1 | |
| SCHEMBL15359113 | 0.92 | DNM1 (0.82) | DNM1EPHX2DGKAMGLLALDH1A1 | |
| SCHEMBL29255836 | 0.92 | DNM1 (0.82) | DNM1EPHX2DGKAMGLLALDH1A1 | |
| SCHEMBL29255775 | 0.92 | DNM1 (0.82) | DNM1EPHX2DGKAMGLLALDH1A1 | |
| SCHEMBL4624499 | 0.92 | DNM1 (0.82) | DNM1EPHX2DGKAMGLLALDH1A1 | |
| SCHEMBL29255924 | 0.92 | DNM1 (0.82) | DNM1EPHX2DGKAMGLLALDH1A1 | |
| SCHEMBL17401280 | 0.92 | DNM1 (0.82) | DNM1EPHX2DGKAMGLLALDH1A1 | |
| SCHEMBL4624502 | 0.92 | DNM1 (0.82) | DNM1EPHX2DGKAMGLLALDH1A1 | |
| SCHEMBL20017985 | 0.92 | DNM1 (0.82) | DNM1EPHX2DGKAMGLLALDH1A1 | |
| Hydrochloric Acid SCHEMBL21778071 | 0.90 | DNM1 (0.79) | DNM1EPHX2DGKAMGLLALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3110905-B1 | QUATERNARY FATTY ACID ESTERS AS CORROSION INHIBITORS | ECOLAB USA INC (US) | 2024-07-17 | — | — | EP | disclosed |
| US-20150240365-A1 | QUATERNARY FATTY ACID ESTERS AS CORROSION INHIBITORS | ECOLAB USA INC. (US) | 2015-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150240365-A1 | QUATERNARY FATTY ACID ESTERS AS CORROSION INHIBITORS | FFAR1, NFKBIA, FFAR2 | DNM1 4578/4885EPHX2 1127/4885DGKA 650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.